Tesla’s Ambitious European Plans, Wal-Mart’s Phone Exchange, and 3 More Hot Stocks
Tesla Motors (NASDAQ:TSLA): Though it’s not revealing any new models or any significant refreshes at this year’s Frankfurt Motor Show in Germany, Tesla is taking the opportunity to introduce its ambitious plans for European expansion. New locations are slated for Vienna, Amsterdam, Paris, London, and Geneva, among others; for existing Tesla owners, the majority of Europe will live within driving distance of a Supercharger station by the end of next year, CEO Elon Musk said.
Wal-Mart (NYSE:WMT): The retail giant has introduced its smartphone trade-in program in the U.S., which will allow shoppers to receive store credit for $50 up to $300 to purchase a new smartphone by trading in their old devices. The program goes live September 21. ”More and more, customers are choosing where they purchase new smartphones based on where they’ll get the best value for their trade-ins,” Steve Bratspies, executive vice president of general merchandise, said in a company statement. “Our goal is to give them more value for their old devices and the lowest price for their new one all part of our promise to be the best destination for wireless.”
UnitedHealth Group (NYSE:UNH): UnitedHealth’s Picis division has recalled software used in emergency departments in hospitals throughout 20 states as a result of a glitch that caused doctors’ notes about patient prescriptions to disappear from their files. The problem also caused a failure to add data to patients’ charts. No reports of harm to patients have surfaced, but the recall could add to concerns about the risks involved with electronic medical records, Seeking Alpha says.
Marathon Oil Corp. (NYSE:MRO): Marathon will be selling its 10 percent working interest in the offshore Angola Block 32 to Sonangol E.P. for $590 million. The company will also acquire 4,800 acres in the core of its south Texas Eagle Ford position for about $97 million. Inclusive of the Angola Block sale, Marathon will have executed $3.5 billion in sales, surpassing the $3 billion upper end of its three-year target.
Walgreens (NYSE:WAG): The pharmacy chain will acquire 76 retail drugstores as well as the specialty pharmacy business of the privately held Kerr Drugs. A distribution center is also included in the terms, though Kerr will retain its long-term care pharmacy operations. The financial terms were not disclosed. Walgreens said that Kerr’s drugstores and specialty pharmacy operations generated sales of $381 million in 2012.